Christopher Sarchi - Jul 17, 2023 Form 3 Insider Report for Replimune Group, Inc. (REPL)

Role
Chief Commercial Officer
Signature
/s/ Shawn Glidden, as attorney-in-fact
Stock symbol
REPL
Transactions as of
Jul 17, 2023
Transactions value $
$0
Form type
3
Date filed
7/26/2023, 08:00 PM
Next filing
Nov 17, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding REPL Common Stock 55K Jul 17, 2023 Direct F1
holding REPL Common Stock 22.5K Jul 17, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding REPL Employee Stock Option (right to buy) Jul 17, 2023 Common Stock 82.5K $27.20 Direct F3
holding REPL Employee Stock Option (right to buy) Jul 17, 2023 Common Stock 33.8K $17.66 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of the Issuer's common stock issuable upon settlement of restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The Reporting Person was granted 55,000 RSUs on December 30, 2022, 25% of such RSUs will vest on November 15, 2023, and the remainder will vest in three approximately equal annual installments thereafter until November 15, 2026, subject to the Reporting Person's continuous service to the Issuer.
F2 Represents shares of the Issuer's common stock issuable upon settlement of RSUs granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The Reporting Person was granted 22,500 RSUs on April 1, 2023, 25% of such RSUs will vest on May 15, 2024, and the remainder will vest in three approximately equal annual installments thereafter until May 15, 2027, subject to the Reporting Person's continuous service to the Issuer.
F3 25% of the shares underlying this stock option vest on December 30, 2023, and the remainder of the shares underlying this stock option vest in 36 approximately equal monthly installments thereafter.
F4 25% of the shares underlying this stock option vest on April 1, 2024, and the remainder of the shares underlying this stock option vest in 36 approximately equal monthly installments thereafter.

Remarks:

Exhibit List Exhibit 24 - Power of Attorney